Education
About Us
Working with TipRanks
Follow Us
Biotron Limited (BITRF)
:BITRF
BITRF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.06
Previous CloseN/A
Volume100.00K
Average Volume (3M)66.00
Market Cap
$3.97M
Enterprise Value$33.90M
Total Cash (Recent Filing)AU$6.30M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.03
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,804,765,500
10 Day Avg. Volume0
30 Day Avg. Volume66
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1059.75
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Biotron Limited News
PremiumCompany Announcements
Biotron Limited Launches $2.7 Million Rights Issue
PremiumCompany Announcements
Biotron Limited Updates Rights Issue Timetable
PremiumCompany Announcements
Biotron Limited Updates Timetable for Securities Issue
PremiumCompany Announcements
Biotron Limited Announces New Share Offer to Raise Capital
PremiumCompany Announcements
Biotron Limited Addresses Financial Position and Strategic Funding Plans
PremiumCompany Announcements
Biotron Limited Updates Timetable for Securities Issue
PremiumCompany Announcements
Biotron Limited Delays Rights Issue Opening Amid ASIC Queries
PremiumCompany Announcements
Biotron Limited Updates Timetable for Securities Issue---
BITRF FAQ
What was Biotron Limited’s price range in the past 12 months?
Biotron Limited lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
What is Biotron Limited’s market cap?
Biotron Limited’s market cap is $3.97M.
When is Biotron Limited’s upcoming earnings report date?
Biotron Limited’s upcoming earnings report date is Aug 29, 2025 which is in 150 days.
How were Biotron Limited’s earnings last quarter?
Biotron Limited released its earnings results on Feb 28, 2025. The company reported <$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by <$0.001.
Is Biotron Limited overvalued?
According to Wall Street analysts Biotron Limited’s price is currently Overvalued.
Does Biotron Limited pay dividends?
Biotron Limited does not currently pay dividends.
What is Biotron Limited’s EPS estimate?
Biotron Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotron Limited have?
Biotron Limited has 1,804,765,500 shares outstanding.
What happened to Biotron Limited’s price movement after its last earnings report?
Biotron Limited reported an EPS of <$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Biotron Limited?
Currently, no hedge funds are holding shares in BITRF
---
Biotron Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
BITRF Sentiment 70%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
-12.50%
12-Months-Change
Fundamentals
Return on Equity
-119.28%
Trailing 12-Months
Asset Growth
-65.03%
Trailing 12-Months
Company Description
Biotron Limited
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
---
Technical Analysis
Alterity Therapeutics Ltd.
―
Immutep Ltd
―
Prescient Therapeutics Limited
―
PYC Therapeutics Limited
―
---